|
Osteonecrosis of the jaw is a rare condition that can be caused by bisphosphonate medication. It is a serious disorder that causes severe bone destruction or loss. Osteonecrosis of the jaw may be treated with antibiotic rinses, removable mouth pieces, and minor dental work.
Osteonecrosis of the jaw occurs in a small number of people that take bisphosphonate medication. Oral bisphosphonate medication is used to prevent or treat osteoporosis and Paget’s disease, two types of bone thinning diseases. Intravenous bisphosphonate medication is used in cancer treatment. It can reduce bone pain and hypercalcemia, high calcium levels in the blood caused by some types of cancer. The risk for osteonecrosis is higher for people with cancer that are receiving intravenous bisphosphonate than for people receiving oral bisphosphonate.
The risk for osteonecrosis of the jaw appears to be higher for people that have dental surgery or invasive dental procedures, such as tooth extraction, while taking bisphosphonate medication. However, the condition can also occur on its own during the period that bisphosphonate medication is used. The risk for developing the condition is lower among people that have non-invasive dental procedures, such as root canals, cleanings, and fillings, after taking the medication.
|